These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10189557)

  • 21. Introduction: New insight into understanding the relation of type 2 diabetes mellitus, insulin resistance, and cardiovascular disease.
    Hsueh WA
    Am J Cardiol; 2003 Aug; 92(4A):1J-2J. PubMed ID: 12957320
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of obesity: need to focus on high risk abdominally obese patients.
    Després JP; Lemieux I; Prud'homme D
    BMJ; 2001 Mar; 322(7288):716-20. PubMed ID: 11264213
    [No Abstract]   [Full Text] [Related]  

  • 23. Epidemiology and factor analysis of obesity, type II diabetes, hypertension, and dyslipidemia (syndrome X) on the Island of Kosrae, Federated States of Micronesia.
    Shmulewitz D; Auerbach SB; Lehner T; Blundell ML; Winick JD; Youngman LD; Skilling V; Heath SC; Ott J; Stoffel M; Breslow JL; Friedman JM
    Hum Hered; 2001; 51(1-2):8-19. PubMed ID: 11096265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visceral obesity, insulin resistance, and dyslipidemia: contribution of endurance exercise training to the treatment of the plurimetabolic syndrome.
    Després JP
    Exerc Sport Sci Rev; 1997; 25():271-300. PubMed ID: 9213095
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical implications of insulin resistance syndromes.
    Davidson MB
    Am J Med; 1995 Oct; 99(4):420-6. PubMed ID: 7573099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin resistance and lipid metabolism.
    Howard BV
    Am J Cardiol; 1999 Jul; 84(1A):28J-32J. PubMed ID: 10418856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fish oil reduces subclinical inflammation, insulin resistance, and atherogenic factors in overweight/obese type 2 diabetes mellitus patients: A pre-post pilot study.
    Souza DR; Pieri BLDS; Comim VH; Marques SO; Luciano TF; Rodrigues MS; De Souza CT
    J Diabetes Complications; 2020 May; 34(5):107553. PubMed ID: 32014347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adolescent obesity and cardiovascular risk.
    Rocchini AP
    Pediatr Ann; 1992 Apr; 21(4):235-40. PubMed ID: 1561003
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
    Bonora E; Kiechl S; Willeit J; Oberhollenzer F; Egger G; Targher G; Alberiche M; Bonadonna RC; Muggeo M
    Diabetes; 1998 Oct; 47(10):1643-9. PubMed ID: 9753305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperinsulinism and dyslipidemias as coronary heart disease risk factors in NIDDM.
    Taskinen MR
    Adv Exp Med Biol; 1993; 334():295-301. PubMed ID: 8249693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome.
    Reusch JE
    Am J Cardiol; 2002 Sep; 90(5A):19G-26G. PubMed ID: 12231075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature.
    Türkoglu C; Duman BS; Günay D; Cagatay P; Ozcan R; Büyükdevrim AS
    Obes Surg; 2003 Oct; 13(5):699-705. PubMed ID: 14627463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular starvation in the insulin resistance syndrome and type II diabetes mellitus.
    Fournier AM
    Med Hypotheses; 1998 Aug; 51(2):95-9. PubMed ID: 9881813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance.
    Watson KE; Peters Harmel AL; Matson G
    J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):253-60. PubMed ID: 14740074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance?
    Li N; Fu J; Koonen DP; Kuivenhoven JA; Snieder H; Hofker MH
    Atherosclerosis; 2014 Mar; 233(1):130-8. PubMed ID: 24529133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance syndrome: options for treatment.
    Granberry MC; Fonseca VA
    South Med J; 1999 Jan; 92(1):2-15. PubMed ID: 9932820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance and compensatory insulin secretion in middle-aged persons with hypertriglyceridemia.
    Kvapil M; Stolba P; Wichterle D; Dvorák P
    Ann N Y Acad Sci; 1993 Jun; 683():295-301. PubMed ID: 8352451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of metabolic syndrome components with insulin resistance in normal weight population: the Qazvin Metabolic Diseases study.
    Hashemipour S; Esmailzadehha N; Hamid H; Oveisi S; Yakhchaliha P; Ziaee A
    J Endocrinol Invest; 2015 Oct; 38(10):1111-5. PubMed ID: 25952300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of components of insulin resistance syndrome to coronary disease risk.
    Després JP; Marette A
    Curr Opin Lipidol; 1994 Aug; 5(4):274-89. PubMed ID: 7981959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromium deficiency might contribute to insulin resistance, type 2 diabetes mellitus, dyslipidaemia, and atherosclerosis.
    Mahdi GS
    Diabet Med; 1996 Apr; 13(4):389-90. PubMed ID: 9162617
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.